Yemelyanova AV - Search Results

1

Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.

Roszik J, Ring KL, Wani KM, Lazar AJ, Yemelyanova AV, Soliman PT, Frumovitz M, Jazaeri AA. Roszik J, et al. Among authors: yemelyanova av. Front Immunol. 2018 Sep 19;9:2102. doi: 10.3389/fimmu.2018.02102. eCollection 2018. Front Immunol. 2018. PMID: 30283446 Free PMC article.

2

Potential immunotherapy targets in recurrent cervical cancer.

Ring KL, Yemelyanova AV, Soliman PT, Frumovitz MM, Jazaeri AA. Ring KL, et al. Among authors: yemelyanova av. Gynecol Oncol. 2017 Jun;145(3):462-468. doi: 10.1016/j.ygyno.2017.02.027. Epub 2017 Feb 21. Gynecol Oncol. 2017. PMID: 28233576

3

Challenges in next generation sequencing analysis of somatic mutations in transplant patients.

Chen H, Luthra R, Patel KP, Routbort M, Rashid A, Roy-Chowdhuri S, Lazar A, Broaddus R, Manekia J, Singh RR, Yemelyanova A. Chen H, et al. Cancer Genet. 2018 Oct;226-227:17-22. doi: 10.1016/j.cancergen.2018.04.119. Epub 2018 May 10. Cancer Genet. 2018. PMID: 30005850

4

Prevention of cancer by prophylactic human papillomavirus vaccines.

Kwak K, Yemelyanova A, Roden RB. Kwak K, et al. Curr Opin Immunol. 2011 Apr;23(2):244-51. doi: 10.1016/j.coi.2010.11.009. Epub 2010 Dec 23. Curr Opin Immunol. 2011. PMID: 21185706 Free PMC article. Review.

5

PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.

Yemelyanova A, Gown AM, Wu LS, Holmes BJ, Ronnett BM, Vang R. Yemelyanova A, et al. Int J Gynecol Pathol. 2014 Sep;33(5):492-9. doi: 10.1097/PGP.0b013e3182a54afa. Int J Gynecol Pathol. 2014. PMID: 25083965

6

Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumors.

Bashir S, Jiang G, Joshi A, Miller C Jr, Matrai C, Yemelyanova A, Caputo TA, Holcomb KM, Ellenson LH, Gupta D. Bashir S, et al. Int J Gynecol Cancer. 2014 Sep;24(7):1262-7. doi: 10.1097/IGC.0000000000000183. Int J Gynecol Cancer. 2014. PMID: 25078343

7

Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival.

Giuntoli RL 2nd, Gerardi MA, Yemelyanova AV, Ueda SM, Fleury AC, Diaz-Montes TP, Bristow RE. Giuntoli RL 2nd, et al. Among authors: yemelyanova av. Int J Gynecol Cancer. 2012 Feb;22(2):273-9. doi: 10.1097/IGC.0b013e318238df4d. Int J Gynecol Cancer. 2012. PMID: 22146771

8

Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.

Liang L, Olar A, Niu N, Jiang Y, Cheng W, Bian XW, Yang W, Zhang J, Yemelyanova A, Malpica A, Zhang Z, Fuller GN, Liu J. Liang L, et al. Am J Surg Pathol. 2016 Jun;40(6):847-56. doi: 10.1097/PAS.0000000000000635. Am J Surg Pathol. 2016. PMID: 26990854 Free PMC article.

9

Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations.

Temkin SM, Smeltzer MP, Dawkins MD, Boehmer LM, Senter L, Black DR, Blank SV, Yemelyanova A, Magliocco AM, Finkel MA, Moore TE, Thaker PH. Temkin SM, et al. Cancer. 2022 Feb 15;128(4):654-664. doi: 10.1002/cncr.34023. Epub 2021 Nov 17. Cancer. 2022. PMID: 34787913 Free PMC article. Review.

10

Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations.

Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl TL, Peng B, Bell D, Routbort M, Hudgens CW, Ivan D, Kim TB, Chen K, Eterovic AK, Shaw K, Prieto VG, Yemelyanova A, Esmaeli B. Tetzlaff MT, et al. Clin Cancer Res. 2019 Feb 15;25(4):1280-1290. doi: 10.1158/1078-0432.CCR-18-1688. Epub 2018 Nov 12. Clin Cancer Res. 2019. PMID: 30420449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page